New oral agents for erectile dysfunction: what is changing in our practice?

Area of Science:

• Urology
• Andrology
• Men's Health

Background:

• Erectile dysfunction (ED) is a widespread condition impacting over 152 million men.
• It is associated with behavioral factors like smoking and alcohol, and medical conditions such as diabetes and cardiovascular disease.

Purpose of the Study:

• To outline a rational, step-wise approach for diagnosing and managing erectile dysfunction.
• To emphasize current diagnostic standards and first-line treatment options.

Main Methods:

• Comprehensive medical and sexual history taking.
• Focused physical examination and essential laboratory tests (fasting glucose, lipid profile, testosterone).
• Evaluation of modifiable risk factors and consideration of oral therapies.

Main Results:

• Specialized diagnostic tests (pharmacotesting, Duplex ultrasound, nocturnal penile tumescence) are no longer considered mandatory.
• Hormonal replacement therapy is reserved for hypogonadal men.
• Oral phosphodiesterase inhibitors or apomorphine are recommended as first-line treatments.

Conclusions:

• A systematic diagnostic approach focusing on history, physical exam, and basic labs is preferred for erectile dysfunction.
• Lifestyle modification and oral pharmacotherapy are key components of ED management.